Zdenko Herceg is a molecular biologist with specialization in epigenetics and cancer research. He is currently Department and Group Head at International Agency for Research on Cancer (Lyon, France).
Prior to joining IARC (1997), he was a post-doctoral scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. He earned his Ph.D. (in 1995) from the University of St Andrews (UK) in the field of oncogenic transformation of human epithelial cells.
He has authored more than 100 original peer-reviewed research publications in the field of epigenetics, mechanisms of carcinogenesis, and cancer research. Recent research projects aims at better understanding of epigenetic mechanisms in human cancer and providing critical information for the development of novel epigenetics-based strategies for cancer prevention and treatment.
Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.